Department of Medicine, Faculty of Medicine, Kuwait University, Safat, Kuwait.
Dig Dis Sci. 2011 Jun;56(6):1656-62. doi: 10.1007/s10620-010-1524-7. Epub 2011 Jan 8.
We investigated the role of toll-like receptor-4 (TLR-4) signal transduction in the regulation of Na-H exchanger-1 isoform (NHE-1) in ulcerative colitis (UC).
Colonic biopsies from control and UC patients were selected from four groups: controls (group 1), untreated UC patients (group 2), UC patients treated with 5'-aminosalicylic acid (5'-ASA) plus steroid (group 3), and UC patients treated with 5'-ASA plus azathioprine (AZA) (group 4). Patients presenting with abdominal pain (n = 13) and a normal colon on endoscopy served as controls. NHE-1, TLR-4, MyD88, NFkB and actin protein levels were estimated using Western blot analysis and sodium pump activity (PNPase) by a spectrophotometeric method. Myeloperoxidase (MPO) activity and histologic evaluation confirmed inflammation.
PNPase activity decreased significantly (P < 0.05) in the untreated UC patients as compared to the controls or treated UC groups 3 and 4. There was a significant decrease of NHE-1 and a significant increase (P < 0.05) of TLR-4, MyD88 and NFkB protein levels in the untreated UC or 5'-ASA plus steroid treated UC patients as compared to the controls. NHE-1, TLR-4, MyD88 and NFkB protein levels were not significantly different in 5'-ASA plus AZA treated biopsies as compared to controls. The level of actin remained unaltered. Inflammatory cells' infiltration and MPO activity increased significantly in the untreated UC, but was significantly lower in the treated UC groups 3 and 4 (P < 0.05).
These findings suggest that NHE-1 in UC is regulated by NFkB induced through TLR-4 and MyD88 signaling mechanism. These findings identify TLR-4 as a putative therapeutic target for IBD.
研究 Toll 样受体 4(TLR-4)信号转导在溃疡性结肠炎(UC)中钠氢交换体-1 同工型(NHE-1)调节中的作用。
从对照组和 UC 患者中选择了来自四个组的结肠活检样本:对照组(第 1 组)、未经治疗的 UC 患者(第 2 组)、接受 5-氨基水杨酸(5-ASA)加类固醇治疗的 UC 患者(第 3 组)和接受 5-ASA 加硫唑嘌呤(AZA)治疗的 UC 患者(第 4 组)。出现腹痛(n=13)且内镜检查正常的患者作为对照组。使用 Western blot 分析和分光光度计法估计 NHE-1、TLR-4、MyD88、NFkB 和肌动蛋白蛋白水平,以及钠泵活性(PNPase)。髓过氧化物酶(MPO)活性和组织学评估证实了炎症的存在。
与对照组或治疗组 3 和 4 相比,未经治疗的 UC 患者的 PNPase 活性显著降低(P<0.05)。与对照组相比,未经治疗的 UC 或 5-ASA 加类固醇治疗的 UC 患者中 NHE-1 显著降低,TLR-4、MyD88 和 NFkB 蛋白水平显著升高(P<0.05)。与对照组相比,5-ASA 加 AZA 治疗的活检中 NHE-1、TLR-4、MyD88 和 NFkB 蛋白水平无显著差异。肌动蛋白水平保持不变。未治疗的 UC 中炎症细胞浸润和 MPO 活性显著增加,但在治疗组 3 和 4 中显著降低(P<0.05)。
这些发现表明,UC 中的 NHE-1 通过 TLR-4 和 MyD88 信号机制调节 NFkB。这些发现确定 TLR-4 是 IBD 的潜在治疗靶点。